Pharmaceutical Industry Blog

Last Updated: July 9, 2026 TL;DR: Mexico — the second-largest pharmaceutical market in Latin America and, with more than 131 million people, one of the largest in the world — depends on a reliable, compliant supply of sterile injectables for its hospitals, its huge public health institutions and its consolidated national tenders, and it imports a significant share of its finished injectables and most of its active ingredients. Every imported sterile injectable must hold a mar

Last Updated: July 9, 2026 TL;DR: Bangladesh — the world's eighth-most-populous country, home to more than 175 million people and one of the most successful pharmaceutical industries in the developing world — meets the overwhelming majority of its own medicine demand from local production and exports finished drugs to well over 100 countries, yet it still imports the great majority of its active pharmaceutical ingredients and the specialised, patented and biologic sterile inj

Last Updated: July 7, 2026 TL;DR: Pakistan — the world's fifth-most-populous country, with more than 240 million people served through public health departments, the Sehat Sahulat programme and a large private sector — needs a dependable, compliant supply of sterile injectables for its hospitals, tender programmes and immunisation and disease-control drives. A significant share of finished injectables and most active ingredients are imported, and every imported product must b

Last Updated: July 7, 2026 TL;DR: Indonesia — the world's fourth-most-populous nation, an archipelago of more than 270 million people served by the JKN universal health-coverage scheme through BPJS Kesehatan — depends on a reliable, compliant supply of sterile injectables for its hospitals, clinics and government tenders, and it imports a large share of its finished injectables and most of its active ingredients. Every imported sterile injectable must be registered with BPOM

A first-principles guide to sterile injectable formulations and how Farbe Firma's WHO-GMP Gujarat facility supports CDMO partners across critical-care, anaesthesia, and anti-infective portfolios.

Third-party pharmaceutical manufacturing allows drug companies to leverage specialized facilities and expertise without building their own plants. Farbe Firma Pvt Ltd, a WHO-GMP certified third-party manufacturer in Gujarat, India, produces 100+ sterile.